Cycrimine 是一种具有口服活性的毒蕈碱胆碱能受体M1拮抗剂，能降低帕金森模型中的乙酰胆碱水平。Cycrimine 具有解痉活性，可用于行为和精神障碍的研究。

Cycrimine is an orally active muscarinic cholinergic receptor (mAChR) M1 antagonist, reduces the acetylcholine levels in parkinson model. Cycrimine shows antispasmodic activity, can be used in studies of behavioral and mental disorder [1] [2] [3] [4].

77-39-4

C19H29NO

287.44

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years